2020 8 • • • • 2 1. 2. 3. 4. 5. • 3 Appendix 4 Modalis Therapeutics CRISPR 2016 1 4 4 12 12 6 1 3 3 Modalis Therapeutics EdiGENE Inc. Modalis Therapeutics Inc. CRISPR-GNDM 2016 1 CEO 16-5 Y’s Modalis Therapeutics Inc. (51 Moulton st. Cambridge MA) CRISPR 4F 2016 2017 2017 2017 2018 2019 2019 J-Startup 1,300,000 41.1 2019 2019 8 Corporation EdiGENE Inc. Modalis Therapeutics Inc. 2 CRISPR-GNDM Editas Medicine, Inc. CRISPR/Cas9 25,100,000 ( 17 ( [ ]4 J-STARTUP 2,903,200 ) PhD 7 2019 2019 2020 9 11 4 2020 5 31 [ ]13 2018 5 Modalis Therapeutics 6 next big thing関連タグ: